Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0541 USD | -7.68% | -0.73% | +46.22% |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 8.59M |
---|---|---|---|---|---|
Net income 2021 | -17M | Net income 2022 | -19M | EV / Sales 2021 | - |
Net cash position 2021 | 23.78M | Net cash position 2022 | 6.72M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.66
x | P/E ratio 2022 |
-0.43
x | Employees | 18 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.97% |
Latest transcript on Bellerophon Therapeutics, Inc.
1 day | -7.68% | ||
1 week | -0.73% | ||
Current month | -4.75% | ||
1 month | -1.64% | ||
3 months | -6.72% | ||
6 months | -1.64% | ||
Current year | +46.22% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | - |
Martin Dekker
CTO | Chief Tech/Sci/R&D Officer | 51 | 15-01-28 |
Edwin L. Parsley
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Naseem Amin
CHM | Chairman | 62 | 15-06-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.0541 | -7.68% | 47,040 |
24-04-23 | 0.0586 | +14.68% | 5,012 |
24-04-22 | 0.0511 | -6.07% | 2,320 |
24-04-19 | 0.0544 | -4.73% | 53,937 |
24-04-18 | 0.0571 | +4.77% | 1,752 |
Delayed Quote OTC Markets, April 24, 2024 at 11:47 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+46.22% | 662K | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.51% | 22.2B | |
-16.53% | 21.23B | |
-8.77% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- BLPH Stock